Cancer News and Research

Latest Cancer News and Research

Costs of lower cognitive ability linked with not breastfeeding amount to over $300 billion each year

When countries, rich or poor, support breastfeeding through meaningful investments and programs, it has an impact on their bottom line and the health of women and children. The Lancet Breastfeeding Series, released today, finds that globally, the costs of lower cognitive ability associated with not breastfeeding amount to more than $300 billion each year, a figure comparable to the entire global pharmaceutical market.

29 Jan 2016

Refugee women have higher risk of giving birth too early than non-refugee immigrants

Refugee women who come to Canada have greater risk of giving birth prematurely than non-refugee immigrants, a study by a St. Michael's Hospital researcher has found. Those risks are fueled by the fact that the preterm birth rate was 7.1 per cent among secondary refugees - those who spent more than six months in a transit country before arriving in Canada -compared to five per cent among secondary, non-refugee immigrants.

29 Jan 2016

New SBP research may lead to novel approach to treat heart failure

More than 5 million people in the United States suffer from heart failure, according to the American Heart Association. Less than half of those with heart failure live five years after diagnosis.

29 Jan 2016

CNIO team uses network theory to build and study first epigenetic communication network

One of the big questions for which there is still no clear answer in biology is how, based on the four universal letters that make up DNA, it is possible to generate such different organisms as a fly or a human, or the different organs and tissues they comprise. In recent years, researchers have discovered that the system is much more complicated than was originally thought.

29 Jan 2016

Second-hand smoke exposure linked to larger waist, poorer cognition in children

Exposure to second-hand smoke is associated with a larger waist and poorer cognition in children, researchers say.

29 Jan 2016

Genetic mutations could help explain cause of cancer in pediatric patients

Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.

29 Jan 2016

VARI-SU2C Epigenetics Dream Team supports new clinical trial that targets metastatic colorectal cancer

The first clinical trial to move forward as part of the Van Andel Research Institute-Stand Up To Cancer (VARI-SU2C) Epigenetics Dream Team will target metastatic colorectal cancer, the second leading cause of cancer deaths among men and women combined in the U.S.

29 Jan 2016

Mutation or amplification of HER2 gene may lead to lung cancer

A joint study by University of Colorado Cancer Center and Memorial Sloan Kettering Cancer Center published in the Journal of Thoracic Oncology shows two distinct causes of HER2 activation in lung cancer: mutation of the gene and amplification of the gene.

29 Jan 2016

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

29 Jan 2016

Scientists discover epigenetic switch linked to obesity

It is well known that a predisposition to adiposity lies in our genes. A new study by researchers at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg now shows that it is also crucial how these genes are regulated. The scientists led by Andrew Pospisilik discovered a novel regulatory, epigenetic switch, which causes individuals with identical genetic material, such as monozygotic twins, to either be lean or obese.

29 Jan 2016

Study provides detailed new information about diffuse glioma

An international collaborative study has revealed detailed new information about diffuse glioma, the most common type of tumor found in some 80 percent of adult brain cancer patients, raising hopes that better understanding of these disease groups may aid improved clinical outcomes.

29 Jan 2016

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.

28 Jan 2016

Researchers discover potential candidates for development of novel targeted therapies for blood cancers

A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute has discovered a new class of small-molecule compounds that are good candidates for development of novel targeted therapies in the treatment of leukemia and lymphoma.

28 Jan 2016

Researchers identify cells that likely give rise to Group 4 medulloblastoma

Researchers have identified the cells that likely give rise to the brain tumor subtype Group 4 medulloblastoma. The finding removes a barrier to developing more effective targeted therapies against the brain tumor's most common subtype.

28 Jan 2016

Three RIT students awarded top honors for research on bio-separation techniques

Three students from Rochester Institute of Technology were recognized for their research findings about improvements to bio-separation techniques for lab-on-a-chip medical devices. They were awarded top honors in several categories in the undergraduate and graduate research competitions at the American Institute of Chemical Engineers annual meeting and conference in November in Salt Lake City, Utah.

28 Jan 2016

Scientists pin down molecular process linked to schizophrenia origin

For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.

28 Jan 2016

Insights into exosomes role in disease transmission gained using NanoSight from Malvern

Data measured using the NanoSight NS300 from Malvern Panalytical is providing new insights into the role of exosomes in diseases such as cancer, arthritis, Alzheimer’s disease and cystic fibrosis, in pioneering research at the University of Alabama - Birmingham (UAB).

From Malvern Panalytical 28 Jan 2016

EHCI: European healthcare steadily improving

European healthcare is steadily improving, in spite of alarm bells about financial crisis austerity measures, aging population and migration turmoil.

28 Jan 2016

New breakthrough drug shows promise to fight antibiotic-resistant infections

A New York pharmaceutical company, TGV-Laboratories, has developed a groundbreaking drug that shows promise in treating a wide variety of antibiotic-resistant fungal and bacterial infections.

28 Jan 2016

New prognostic biomarker may help determine risk of prostate cancer-related death

Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type of protein is very specific to prostate cancer cells and could help identify whether newly diagnosed patients require radical prostatectomy surgery or if it is safe to delay surgery.

28 Jan 2016

Cancer News and Research

Latest Cancer News and Research

Costs of lower cognitive ability linked with not breastfeeding amount to over $300 billion each year

Refugee women have higher risk of giving birth too early than non-refugee immigrants

New SBP research may lead to novel approach to treat heart failure

CNIO team uses network theory to build and study first epigenetic communication network

Second-hand smoke exposure linked to larger waist, poorer cognition in children

Genetic mutations could help explain cause of cancer in pediatric patients

VARI-SU2C Epigenetics Dream Team supports new clinical trial that targets metastatic colorectal cancer

Mutation or amplification of HER2 gene may lead to lung cancer

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

Scientists discover epigenetic switch linked to obesity

Study provides detailed new information about diffuse glioma

Halaven (eribulin mesylate) approved for treatment of liposarcoma

Researchers discover potential candidates for development of novel targeted therapies for blood cancers

Researchers identify cells that likely give rise to Group 4 medulloblastoma

Three RIT students awarded top honors for research on bio-separation techniques

Scientists pin down molecular process linked to schizophrenia origin

Insights into exosomes role in disease transmission gained using NanoSight from Malvern

EHCI: European healthcare steadily improving

New breakthrough drug shows promise to fight antibiotic-resistant infections

New prognostic biomarker may help determine risk of prostate cancer-related death

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Newsletters you may be interested in